“Repurposing of Thalidomide as a Potential Therapeutic Agent for Idiopathic Pulmonary Fibrosis: An In Silico Molecular Docking Study” (2026) International Journal of Research in Pharmaceutical Sciences and Technology, 9(3). doi:10.33974/st7x9s50.